LAMA2-Related Muscular Dystrophy: The Importance of Accurate Phenotyping and Brain Imaging in the Diagnosis of LGMD.

We report three siblings from a non-consanguineous family presenting a with contractural limb-girdle phenotype with intrafamilial variability. Muscle MRI showed posterior thigh and quadriceps involvement with a sandwich-like sign. Whole-exome sequencing identified two compound heterozygous missense TTN variants and one heterozygous LAMA2 variant. Brain MRI performed because of concentration difficulties in one of the siblings evidenced white-matter abnormalities, subsequently found in the others. The genetic analysis was re-oriented, revealing a novel pathogenic intronic LAMA2 variant which confirmed the LAMA2-RD diagnosis. This work highlights the importance of a thorough clinical phenotyping and the importance of brain imaging, in order to orientate and interpret the genetic analysis.

[1]  F. Sicca,et al.  Epilepsy in LAMA2-related muscular dystrophy: A systematic review of the literature , 2021, Seizure.

[2]  B. Udd.  The constantly evolving spectrum of phenotypes in titinopathies – will it ever stop? , 2020, Current opinion in neurology.

[3]  F. Muntoni,et al.  LAMA2-Related Dystrophies: Clinical Phenotypes, Disease Biomarkers, and Clinical Trial Readiness , 2020, Frontiers in Molecular Neuroscience.

[4]  H. Colognato,et al.  Brain Dysfunction in LAMA2-Related Congenital Muscular Dystrophy: Lessons From Human Case Reports and Mouse Models , 2020, Frontiers in Molecular Neuroscience.

[5]  N. Bresolin,et al.  Limb girdle muscular dystrophy due to LAMA2 gene mutations: new mutations expand the clinical spectrum of a still challenging diagnosis , 2020, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[6]  S. Previtali,et al.  LAMA2 Neuropathies: Human Findings and Pathomechanisms From Mouse Models , 2020, Frontiers in Molecular Neuroscience.

[7]  D. Cuadras,et al.  Epilepsy in LAMA2‐related muscular dystrophy: An electro‐clinico‐radiological characterization , 2020, Epilepsia.

[8]  K. Lim,et al.  Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy , 2019, The application of clinical genetics.

[9]  J. D. den Dunnen,et al.  LAMA2 gene mutation update: Toward a more comprehensive picture of the laminin‐α2 variome and its related phenotypes , 2018, Human mutation.

[10]  Beryl B. Cummings,et al.  Congenital Titinopathy: Comprehensive characterization and pathogenic insights , 2018, Annals of neurology.

[11]  Marika Pane,et al.  Interpreting Genetic Variants in Titin in Patients With Muscle Disorders , 2018, JAMA neurology.

[12]  M. Rüegg,et al.  Laminin-deficient muscular dystrophy: Molecular pathogenesis and structural repair strategies. , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[13]  K. Bushby,et al.  Congenital muscular dystrophies in the UK population: Clinical and molecular spectrum of a large cohort diagnosed over a 12-year period , 2017, Neuromuscular Disorders.

[14]  I. Nelson,et al.  A new titinopathy , 2015, Neurology.

[15]  C. Béroud,et al.  Laminin α2 Deficiency-Related Muscular Dystrophy Mimicking Emery-Dreifuss and Collagen VI related Diseases , 2015, Journal of neuromuscular diseases.

[16]  F. Muntoni,et al.  Limb girdle muscular dystrophy due to LAMA2 mutations: Diagnostic difficulties due to associated peripheral neuropathy , 2014, Neuromuscular Disorders.

[17]  B. Eymard,et al.  Muscle diseases with prominent joint contractures: Main entities and diagnostic strategy. , 2013, Revue neurologique.

[18]  A. Mateddu,et al.  Dilated cardiomyopathy with conduction defects in a patient with partial merosin deficiency due to mutations in the laminin‐α2‐chain gene: A chance association or a novel phenotype? , 2011, Muscle & nerve.

[19]  K. Bushby,et al.  Genotype–phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations , 2010, Neuromuscular Disorders.

[20]  J. Allsop,et al.  Muscle MRI in Ullrich congenital muscular dystrophy and Bethlem myopathy , 2005, Neuromuscular Disorders.

[21]  C. Angelini,et al.  Genetic epidemiology of congenital muscular dystrophy in a sample from north-east Italy , 1996, Human Genetics.

[22]  J. Jinkins,et al.  Merosin-deficient congenital muscular dystrophy (CMD): a study of 25 Brazilian patients using MRI , 2005, Pediatric Radiology.

[23]  C. Angelini,et al.  LAMA2 loss-of-function mutation in a girl with a mild congenital muscular dystrophy , 2004, Neurology.

[24]  K. North,et al.  The expanding phenotype of laminin α2 chain (merosin) abnormalities: case series and review , 2001, Journal of medical genetics.

[25]  G. Bydder,et al.  Merosin-deficient congenital muscular dystrophy: the spectrum of brain involvement on magnetic resonance imaging , 1999, Neuromuscular Disorders.

[26]  C. Pantaleoni,et al.  Congenital muscular dystrophy with merosin deficiency: MRI findings in five patients , 1998, Neuroradiology.

[27]  F. Muntoni,et al.  Evidence of left ventricular dysfunction in children with merosin-deficient congenital muscular dystrophy. , 1998, American heart journal.

[28]  T. Crawford,et al.  Laminin α2 muscular dystrophy , 1998, Neurology.

[29]  K. Bushby,et al.  Abnormal merosin in adults. A new form of late onset muscular dystrophy not linked to chromosome 6q2. , 1998, Brain : a journal of neurology.

[30]  F. Muntoni,et al.  Variable clinical phenotype in merosin-deficient congenital muscular dystrophy associated with differential immunolabelling of two fragments of the laminin α2 chain , 1997, Neuromuscular Disorders.

[31]  K. Campbell,et al.  Mild congenital muscular dystrophy in two patients with an internally deleted laminin alpha2-chain. , 1997, Human molecular genetics.

[32]  K. Tryggvason,et al.  Structure of the Human Laminin α2-Chain Gene (LAMA2), Which Is Affected in Congenital Muscular Dystrophy* , 1996, The Journal of Biological Chemistry.

[33]  F. Muntoni,et al.  Demyelinating Peripheral Neuropathy in Merosin-Deficient Congenital Muscular Dystrophy , 1995, Journal of child neurology.

[34]  J. Weissenbach,et al.  Mutations in the laminin α2–chain gene (LAMA2) cause merosin–deficient congenital muscular dystrophy , 1995, Nature Genetics.